Fecal microbiota transplantation (FMT) is the process by which fecal microbiota are donated
from a healthy individual and subsequently transplanted into a diseased or young individual …

Background There is growing interest in faecal microbiota transplantation (FMT) as a
treatment for recurrent Clostridioides difficile infection (CDI), but evidence on the diverse …

Background Faecal microbiota transplantation is an emerging therapeutic option,
particularly for the treatment of recurrent Clostridioides difficile infection. Stool banks that …

Background Faecal microbiota transplantation (FMT) is increasingly being used in the
treatment of recurrent Clostridioides difficile infection (rCDI). Health economic evaluations …

The past 2 years have brought exciting developments to microbiome-based therapeutics
(MBT)—products derived or prepared from human stool—for recurrent Clostridioides difficile …

Clostridioides difficile is the leading cause of antibiotic-associated infectious diarrhea. The
development of C. difficile infection is tied to perturbations of the bacterial community in the …

Background: The success of fecal microbiota transplantation (FMT) programs depends on
maintaining suitable stool donors. We describe challenges recruiting and retaining universal …

Clostridioides difficile infection (CDI) remains a significant contributor to healthcare costs
and morbidity due to high rates of recurrence. Currently, available antibiotic treatment …

Background Fecal microbiota transplantation (FMT) and fecal virome transplantation (FVT,
sterile filtrated donor feces) have been effective in treating recurrent Clostridioides difficile …

The aim of this study is to evaluate the specific bacterial communities and alterations and to
explore the method predicting the microbiological evolution tendency of ulcerative colitis …